Kapidex and Breastfeeding
According to the manufacturer of Kapidex (dexlansoprazole), women who are nursing should avoid this medication. It is not known if the medicine passes through breast milk, but studies with a similar product show that Kapidex could theoretically increase the risk of cancers or tumors in breastfeeding women. Before taking Kapidex, nursing women should talk to their healthcare providers about the potential risks.
At this time, it is not known if Kapidex™ (dexlansoprazole) passes through breast milk in humans. The manufacturer of Kapidex recommends that breastfeeding women avoid taking this medication. Therefore, if you are breastfeeding, talk with your healthcare provider before taking Kapidex.
Starting April 2010, the name for Kapidex was officially changed to Dexilant™. The name was changed because it was too similar to the names of a few other drugs, leading to a few "mix-ups." Please see our Dexilant articles within eMedTV.com for current information about this medication.
No studies have been done to see if Kapidex passes through breast milk in humans or in animals. Studies have shown that lansoprazole (a very similar medication) passes through breast milk in rats. The manufacturer of Kapidex suggests that breastfeeding women avoid taking Kapidex, as there is a theoretical increased risk of cancers or tumors (based on studies of lansoprazole in rats).
Because of the unknown risks, a different medication may be a better option.
You should talk with your healthcare provider about breastfeeding and Kapidex. Each woman's situation is different, and you and your healthcare provider understand your situation best. After considering what you want and expect, as well as your current health situation, the two of you can make a shared decision that is right for you.